Annual report pursuant to Section 13 and 15(d)

Loss Per Share (Details Narrative)

v3.21.1
Loss Per Share (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Stock options exercisable 349,642  
Antidilutive securities excluded from computation of earnings per share, amount 2,842,211 547,131
Common stock, shares outstanding 5,995,320 1,403,759
Convertible Debt [Member]    
Convertible common stock shares   2,500
Convertible note payable   $ 50,000
Series D Preferred Stock [Member]    
Antidilutive securities excluded from computation of earnings per share, amount 10  
Convertible common stock shares 4,748  
Stock Option [Member]    
Stock options exercisable 713,010 180,903
Antidilutive securities excluded from computation of earnings per share, amount 713,010 180,903
Common stock, shares outstanding 2,842,211 547,131
Warrants [Member]    
Warrants Outstanding 1,881,429 363,728
Conversion of common stock 1,881,429 363,728
Preferred Stock [Member]    
Convertible common stock shares 715  
Common Stock [Member]    
Convertible common stock shares 243,024